Bullish
TD Cowen raises DexCom stock price target to $95 on data
TD Cowen increased its price target for DexCom Inc. (NASDAQ:DXCM) shares to $95 from $75, maintaining a Buy rating, after new data was presented at th...
DXCM
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (15)
Neutral (4)
Bearish (0)
Latest DXCM News
Bullish
Bullish
Mizuho raises Dexcom stock price target to $85 on diabetes study
Mizuho increased its price target for DexCom Inc. (NASDAQ:DXCM) shares to $85 from $75, maintaining an Outperform rating, following positive results f...
Bullish
Mizuho Securities Adjusts DexCom Price Target to $85 From $75, Maintains Outperform Rating
Mizuho Securities has increased its price target for DexCom (DXCM) to $85 from $75, while reiterating an "Outperform" rating on the stock. This adjust...
Stifel Adjusts Price Target on DexCom to $90 From $85, Maintains Buy Rating
Stifel has raised its price target for DexCom (DXCM) to $90 from $85, reiterating a Buy rating on the stock. This adjustment comes amidst recent news ...
Bullish
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
Dexcom has released its first Customer Advisory Council Report, detailing user feedback and outlining actionable commitments to improve product perfor...
Bullish
Dexcom vows easier sensor replacements after frank user feedback
Dexcom has released its inaugural Customer Advisory Council Report, detailing user feedback and outlining six commitments to enhance product performan...
Bullish
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
Dexcom has released its first Customer Advisory Council Report, detailing user feedback and the company's commitments to improving product performance...
Bullish
Signos raises $20M, expands Dexcom partnership for weight loss
Signos has successfully raised $20 million in funding. The company also announced an expansion of its partnership with Dexcom, focusing on initiatives...
Bullish
Goldman Sachs Adjusts Price Target on DexCom to $85 From $80, Maintains Buy Rating
Goldman Sachs has raised its price target for DexCom (DXCM) to $85 from $80, while reiterating a Buy rating on the stock. This adjustment comes after ...
Neutral
Dexcom recalls stolen G7 sensors sold by unauthorized vendor
Dexcom has issued a recall for two lots of G7 sensors (1725204004 and 1725069002) that were stolen before destruction and subsequently sold by an unau...
Neutral
Does DexCom’s (DXCM) Flex Launch in Germany Hint at a Broader CGM Access Strategy Shift?
DexCom recently launched Dexcom Flex in Germany, a continuous glucose monitoring (CGM) system for Type 2 diabetes patients not on intensive insulin th...
Bullish
Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery
Alpha Wealth Funds, LLC, in its Q1 2026 investor letter, highlighted DexCom, Inc. (NASDAQ:DXCM) despite losing 7.14% in the quarter due to the War in ...
Bullish
DexCom (DXCM) Introduces Dexcom Flex for Type 2 Diabetes Patients
DexCom (DXCM) has launched its new continuous glucose monitoring (CGM) system, Dexcom Flex, designed for adults with Type 2 diabetes who do not use in...
Neutral
BofA Securities Adjusts Price Target on DexCom to $80 From $100
BofA Securities has lowered its price target for DexCom (NASDAQ:DXCM) shares from $100 to $80. The article mentions this change and provides market da...
Bullish
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
Dexcom has announced Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with Type 2 diabetes who do not use intensive i...
Bullish
DexCom Stock Jumps After Diabetes Management Firm Reaches Agreement With Elliott Investment Management
DexCom's stock surged almost 7% after activist investor Elliott Investment Management took a major stake and reached a cooperation agreement with the ...
Bullish
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
DexCom outlined its long-term growth plan during its 2026 Investor Day, targeting over 10% annual revenue growth through 2030, along with margin expan...
Bullish
DexCom, Inc. announces an Equity Buyback for $1,000 million worth of its shares.
DexCom, Inc. (NasdaqGS:DXCM) has announced a share repurchase program, committing to buy back up to $1,000 million worth of its shares. This program i...
Neutral
Benchmark reaffirms Dexcom stock rating after growth strategy event
Benchmark reiterated a Buy rating and $77.00 price target on Dexcom (NASDAQ:DXCM) shares after the company's investor event. Dexcom outlined a new gro...
Research DXCM on:
Ad Space